# LSC-BIO HC1, DST: Form D filings

LSC-BIO HC1, DST, a biotechnology company in Radnor, PA, filed 4 Form D notices with the SEC between 2017 and 2018. The latest, on March 2, 2018, reports $4.5 million sold of a $4.5 million offering to 12 investors.

Find out what LSC-BIO HC1, DST does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20LSC-BIO%20HC1%2C%20DST%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=LSC-BIO%20HC1%2C%20DST&page=%2Fdata%2Fform-d%2Fcompany%2Flsc-bio-hc1-dst-1725079)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20LSC-BIO%20HC1%2C%20DST%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=LSC-BIO%20HC1%2C%20DST&page=%2Fdata%2Fform-d%2Fcompany%2Flsc-bio-hc1-dst-1725079)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pennsylvania](https://specstream.ai/data/form-d/state/pennsylvania): 987 rows, by operating companies, filed since November 1, 2024, $49.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/pennsylvania
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 595 EAST LANCASTER AVENUE, SUITE 300, Radnor, PA, 19087
- Phone: (855) 434-2233
- Industry: Biotechnology
- Entity type: Business Trust
- Incorporated in: Delaware
- Year incorporated: 2017
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1725079

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 2, 2018 | Amendment | $4,453,890 | $4,453,890 | $0 | 12 | Nov 29, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1725079/000172507918000003/0001725079-18-000003-index.htm) |
| Feb 23, 2018 | Amendment | $4,453,890 | $4,083,610 | $370,280 | 11 | Nov 29, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1725079/000172507918000002/0001725079-18-000002-index.htm) |
| Dec 26, 2017 | Amendment | $4,453,890 | $3,561,610 | $892,280 | 7 | Nov 29, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1725079/000172507917000003/0001725079-17-000003-index.htm) |
| Dec 13, 2017 | New notice | $4,453,890 | $2,603,701 | $1,850,189 | 3 | Nov 29, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1725079/000172507917000002/0001725079-17-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| - Livingston Capital, LLC | Promoter |  |
| Pietro Scola | Executive Officer |  |

## Other biotechnology companies in Pennsylvania that filed recently

- [Traws Pharma, Inc.](https://specstream.ai/data/form-d/company/traws-pharma-inc-1130598) offering · Nov 5, 2026
- [BioLattice Ophthalmics, Inc,](https://specstream.ai/data/form-d/company/biolattice-ophthalmics-inc-2125596) $1.8 million · Oct 28, 2026
- [Myris Therapeutics, Inc.](https://specstream.ai/data/form-d/company/myris-therapeutics-inc-1924725) $500,000 · Oct 14, 2026
- [Praeventix, Inc.](https://specstream.ai/data/form-d/company/praeventix-inc-1952974) $5.6 million · Sep 10, 2026
- [Plowshare Therapies LLC](https://specstream.ai/data/form-d/company/plowshare-therapies-llc-2152111) $6.7 million · Aug 31, 2026
- [Noveome Biotherapeutics, Inc.](https://specstream.ai/data/form-d/company/noveome-biotherapeutics-inc-1478304) $6.8 million · Aug 27, 2026
- [AlloTRx Bio Inc.](https://specstream.ai/data/form-d/company/allotrx-bio-inc-2151424) $500,000 · Aug 24, 2026
- [Aposture Surgical Corp](https://specstream.ai/data/form-d/company/aposture-surgical-corp-2148299) $87,000 · Aug 13, 2026
- [Merlin Biotech, Inc.](https://specstream.ai/data/form-d/company/merlin-biotech-inc-2149714) $50,000 · Aug 11, 2026

[Every Form D from the week of Feb 26, 2018](https://specstream.ai/data/form-d/week/2018-02-26) · [All recent filings in Pennsylvania](https://specstream.ai/data/form-d/state/pennsylvania) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what LSC-BIO HC1, DST reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).